Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

May 31, 2025

Conditions
Nasal BleedingNasotracheal Intubation
Interventions
DRUG

0.1% xylometazoline nasal drops

Xylometazoline is direct acting, non selective, adrenergic agonist binding with alpha 1\&2 receptors, used for vasoconstriction to decrease nasal bleeding.

DRUG

Adrenaline nasal pack

Adrenaline is direct acting, non selective, adrenergic agonist binding with alpha and beta receptors both, used for vasoconstriction to decrease nasal bleeding.

Trial Locations (1)

Unknown

RECRUITING

Shaheed Mohtarma Benazir Bhutto Institute of Trauma, Karachi

All Listed Sponsors
lead

Shaheed Mohtarma Benazir Bhutto Institue of Trauma

OTHER